Answers are grounded in this paper and cite their sources.
The prognosis of CVT is better than reported previously. A subgroup (13%) of clinically identifiable CVT patients is at increased risk of bad outcome. These high-risk patients may benefit from more aggressive therapeutic interventions, to be studied in randomized clinical trials.
No takes yet. Share an insight, caveat, or question.
Ferro et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: